RC
Robert C. Sugarman
PE
Last researched 3 months ago
Medical Oncology
Gastroenterology
About
Sugarman is associated with a law office rather than a medical or clinical practice. No medical credentials, clinical specialty, or expert witness experience can be confirmed from the available information, and a professional biography in this directory's format cannot responsibly be constructed from the current data.
Credentials
PE
FHFES
Publications
- Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma.
- Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.
- Grounding digital mental health and wellbeing platform development in a theory of change: a convergent mixed methods approach.
- Association between acneiform eruption grade and survival outcomes in EGFRi-treated metastatic colorectal cancer patients: A retrospective cohort study.
- Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial.
- Q-TWiST analysis of first-line nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma from CheckMate 649: 4-year follow-up results.
- Nonoperative Management of Mismatch Repair-Deficient Tumors.
- RNA neoantigen vaccines prime long-lived CD8(+) T cells in pancreatic cancer.
- Hemiplegic migraine associated with etonogestrel 68 mg implant insertion case report.
- Pregnancy-Associated Onset of Adult-Onset Still's Disease.
Request CV and rates
Tell us about your case and we'll connect you with Robert C. Sugarman within two business days.
Other experts
Verified specialists available for your case.
